Bnp-Paribas-Financial-Markets

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
4,665
Total Value
30687523338
Accession Number
0001166588-25-000031
Form Type
13F-HR
Manager Name
Bnp-Paribas-Financial-Markets
Data Enrichment
85% identified
3,953 identified712 unidentified

Holdings

4,665 positions • $30.7B total value
Manager:
Search and click to pin securities to the top
Clene Inc.
Shares:13
Value:$40
% of Portfolio:0.0% ($40/$30.7B)
PEMBINA PIPELINE CORP
Shares:1
Value:$40
% of Portfolio:0.0% ($40/$30.7B)
78463X509
Shares:1
Value:$39
% of Portfolio:0.0% ($39/$30.7B)
HERTZ GLOBAL HOLDINGS, INC
Shares:17
Value:$38
% of Portfolio:0.0% ($38/$30.7B)
46435U663
Shares:1
Value:$38
% of Portfolio:0.0% ($38/$30.7B)
Bionano Genomics, Inc.
Shares:13
Value:$36
% of Portfolio:0.0% ($36/$30.7B)
HOOKIPA Pharma Inc.
Shares:33
Value:$36
% of Portfolio:0.0% ($36/$30.7B)
GAN Ltd
Shares:20
Value:$35
% of Portfolio:0.0% ($35/$30.7B)
Tempest Therapeutics, Inc.
Shares:48
Value:$35
% of Portfolio:0.0% ($35/$30.7B)
Dragonfly Energy Holdings Corp.
Shares:34
Value:$33
% of Portfolio:0.0% ($33/$30.7B)
Avalo Therapeutics, Inc.
Shares:4
Value:$32
% of Portfolio:0.0% ($32/$30.7B)
25459W755
Shares:3
Value:$31
% of Portfolio:0.0% ($31/$30.7B)
BRAINSTORM CELL THERAPEUTICS INC.
Shares:24
Value:$30
% of Portfolio:0.0% ($30/$30.7B)
SYNLOGIC, INC.
Shares:24
Value:$30
% of Portfolio:0.0% ($30/$30.7B)
AYTU BIOPHARMA, INC
Shares:23
Value:$28
% of Portfolio:0.0% ($28/$30.7B)
Marker Therapeutics, Inc.
Shares:23
Value:$28
% of Portfolio:0.0% ($28/$30.7B)
Forian Inc.
Shares:14
Value:$28
% of Portfolio:0.0% ($28/$30.7B)
Alarum Technologies Ltd.
Shares:4
Value:$25
% of Portfolio:0.0% ($25/$30.7B)
Ernexa Therapeutics Inc.
Shares:140
Value:$25
% of Portfolio:0.0% ($25/$30.7B)
Aligos Therapeutics, Inc.
Shares:3
Value:$25
% of Portfolio:0.0% ($25/$30.7B)